Skip to main content
Screener/Healthcare/Biotechnology

TBPH — Theravance Biopharma, Inc.

NASDAQ
$17.00-0.02 (-0.12%)
Small CapUnder $20Healthcare
$8.33
$21.03
$16.61
$17.00
EPS (TTM)$2.20
P/E Ratio7.73
Dividend Yield—
Market Cap$864.6M
Volume155K
Prev Close$17.02
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$17.7M-$4.9M$-0.100.0%-27.9%
Q4 '25$45.9M$61.0M$1.15153.5%133.0%
Q3 '25$20.0M$3.6M$0.0759.4%18.1%
Q2 '25$26.2M$54.8M$1.0860.0%209.3%
Q1 '25$15.4M-$13.6M$-0.2725.6%-88.2%
Q4 '24$18.8M-$15.5M$-0.31100.0%-82.8%
Q3 '24$16.9M-$12.7M$-0.2645.1%-75.3%
Q2 '24$14.3M-$16.5M$-0.3430.2%-115.9%
Get Your Daily Market Recap